Mylan Launches Generic Focalin XR
Dexmethylphenidate HCl is a central nervous system stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
Dexmethylphenidate, the more pharmacologically active d-enantiomer of racemic methylphenidate, is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.
Mylan has been awarded 180 days of marketing exclusivity.
For more information call (800) RX-MYLAN or visit Mylan.com.